Nutex Health (NUTX) Q3 2025 earnings summary

Executive summary

• Achieved record financial performance in Q2 and Q3 2025, with Q3 revenue of $267.8M (up 240% YoY), net income of $55.4M, and adjusted EBITDA of $98.5M, driven by increased patient volumes, higher acuity claims, and arbitration collections.

• For the first nine months of 2025, total revenue was $723.6M (up 225.5% YoY), net income was $59.0M, and adjusted EBITDA reached $243.0M, with strong cash flow from operations.

• Completed restatements for 2024 and Q1 2025 with only minor, non-cash adjustments, confirming no material impact on revenue, EBITDA, or cash positions.

• Operates 24–25 hospital facilities in 11 states, with over 15 facilities in the development pipeline and three new hospitals set to open in 2025.

• Population health management division contributed $23.1M in revenue for the nine months, with over 40,000 patients enrolled in IPAs.

Financial highlights

• Q3 2025 revenue was $267.8M, up 240% YoY; hospital division revenue was $260.2M, up 263%; population health revenue was $7.6M.

• Adjusted EBITDA for Q3 2025 was $98.5M, up from $9.7M; net income was $55.4M versus a loss of $8.8M in Q3 2024.

• Cash and equivalents at September 30, 2025, were $166M, up from $40.6M at year-end 2024; operating cash flow for nine months was $177.7M.

• Diluted EPS for Q3 2025 was $7.76, up from a loss of $1.72 in Q3 2024; for nine months, diluted EPS was $8.87 versus a loss of $1.91 in 2024.

• Gross margin improved to 57.8% in Q3 2025 from 27.8% in Q3 2024; facility-level operating costs fell to 42.2% of revenue.

Outlook and guidance

• On track to open three new hospitals in 2025, with additional openings and IPA launches planned for 2026–2028.

• Continued focus on expanding inpatient services, optimizing costs, and leveraging arbitration for fair reimbursement.

• Management expects further improvement in inpatient utilization and profitability as new service lines and markets mature.

• Positioned for planned growth, supported by a strong balance sheet and record cash balance.